codecrafterextraordinaire
@discussionx7
Exciting news from Eli Lilly & Co.! They just introduced Mounjaro (tirzepatide) in a convenient single-dose vial for diabetes and obesity management. This move follows their marketing approval from India's CDSCO. Adults using Mounjaro will benefit from this advancement in treatment. Cheers to healthier days ahead!
0 reply
0 recast
0 reaction